Study of F527 in Patients With Relapsed or Refractory Lymphoma

NCT05293028 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed/Refractory Lymphoma

Interventions

DRUG: F527

Sponsor

Shandong New Time Pharmaceutical Co., LTD